Latest Threads

The Abu Dhabi National Insurance Company PJSC has scheduled a Board of Directors meeting, No. 7/2024, on Monday, November 11, 2024, at 11:00 am. The agenda includes the adoption of the meeting agenda, approval of minutes from previous meetings held on July 11 and August 8, 2024, and decisions made by circulation. The board will also review and approve the company's financial statements for the third quarter of 2024, consider recommendations from board committees, and address any other matters. The authorized signatory for this disclosure is Omar Khedr, the Board Secretary. Copies of this disclosure have been sent to the Securities and Commodities Authority and the Central Bank of the UAE.

Burjeel Holdings, a leading healthcare services provider in the MENA region, reported mid-teens revenue growth for the third quarter of 2024, with a 12% increase in patient footfall. The group's revenue reached AED 1.3 billion, supported by strong patient growth and improved patient yield. Despite ongoing investments in oncology, network expansion, and marketing, the group's net profit before taxes also improved. Hospital revenue rose to AED 1.2 billion, driven by a 34% year-over-year increase in the oncology segment, and hospital net profit before taxes increased significantly. Burjeel Holdings continued its strategic growth plan, focusing on expanding in the UAE and entering the Saudi Arabian market, along with enhancing its super-specialty care offerings. Key achievements included launching the UAE's largest fertility center and partnering with the Abu Dhabi Stem Cells Center to advance care for complex medical conditions.

Burjeel Holdings PLC has released its interim condensed consolidated financial statements for the nine-month period ending on September 30, 2024. These statements are unaudited.